Detalles de la búsqueda
1.
Model-Informed Selection of the Recommended Phase III Dose of the Inhibitor of Apoptosis Protein Inhibitor, Xevinapant, in Combination with Cisplatin and Concurrent Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck.
Clin Pharmacol Ther
; 115(1): 52-61, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37777832
2.
Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-ß and PD-L1.
Clin Pharmacol Ther
; 108(3): 566-574, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31955412
Resultados
1 -
2
de 2
1
Próxima >
>>